Search

Danielle Mitchell

from Las Vegas, NV
Age ~40
Get Report
Also known as:
Daniell Mitchell, Danielle Michell, Daniel Mitchel
Related to:
Marilyn Mitchell, 39Latosha Ingram, 42Nicole Mitchell, 41Veronica Miller, 56Michelle Heibel, 52
Connected to:
Akia L Mitchell, 38Alexandria C Mitchell, 32Alonzo E Mitchell, 88Altamese N Mitchell, 41Anett R Mitchell, 58Anthwan S Mitchell, 47April D Mitchem, 50Ashlei J Mitchell, 42Atiya K Mitchell, 39Augustine J Mitchell, 74

Danielle Mitchell Phones & Addresses

  • Las Vegas, NV
  • Bremerton, WA

Public records

Vehicle Records

Danielle Mitchell

View page
Address:
5445 W Reno Ave APT 1909, Las Vegas, NV 89118
VIN:
3N1AB61E17L713923
Make:
NISSAN
Model:
SENTRA
Year:
2007

Resumes

Resumes

Danielle Mitchell Photo 1

Danielle Mitchell Las Vegas, NV

View page
Work:
Dottys

Gaming Auditor
The Doctors Clinic
Silverdale, WA
Jul 2012 to Nov 2013
Certified Medical Assistant
Desert Oasis Clinic
Las Vegas, NV
Aug 2010 to May 2012
Medical Assistant
Life Extension Buyers Club
Las Vegas, NV
Jul 2007 to Apr 2009
Member Care Representative
Sitel Corporation
Las Vegas, NV
Jul 2006 to Jul 2007
Customer Service Representative
Education:
Northwest Health Careers
Las Vegas, NV
2010 to 2010
Diploma in Medical Assisting
Clark Ed. High School
Las Vegas, NV
2000
High School Diploma
Danielle Mitchell Photo 2

Danielle Mitchell Tukwila, WA

View page
Work:
Lane Bryant

Sep 2007 to Present
Part Time Sales Leader
Reischling Press Inc
Tukwila, WA
Jun 2008 to Aug 2008
Quality Assurance Inspector; picker; shiper
Park Shore
Seattle, WA
Jun 2006 to Sep 2006
Server
Education:
Cornish College of the Arts
Seattle, WA
May 2012
BFA in Theater
Evergreen High School
Seattle, WA
2007
High School Diploma

Publications

Us Patents

Multi-Copy Strategy For High-Titer And High-Purity Production Of Multi-Subunit Proteins Such As Antibodies In Transformed Microbes Such As Pichia Pastoris

View page
US Patent:
20130045888, Feb 21, 2013
Filed:
Aug 20, 2012
Appl. No.:
13/589584
Inventors:
Danielle Marie Mitchell - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Patricia Dianne McNeill - Federal Way WA, US
Ethan Wayne Ojala - Snohomish WA, US
Mehmet Inan - Antalya, TR
John Latham - Seattle WA, US
International Classification:
C40B 30/04
C12P 21/00
C12N 1/19
US Classification:
506 9, 4352551, 4352555, 435 696
Abstract:
Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subunit proteins, which may or may not be secreted, with a higher yield and decreased production of undesired side-products. In exemplary embodiments, the transformed cells are a yeast, e.g., methylotrophic yeast such as

Anti-Pcsk9 Antibodies And Use Thereof

View page
US Patent:
20130302399, Nov 14, 2013
Filed:
Mar 12, 2013
Appl. No.:
13/795674
Inventors:
Andrew Lawrence Feldhaus - Lynnwood WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Benjamin H. Dutzar - Seattle WA, US
Ethan Wayne Ojala - Snohomish WA, US
Brian Robert Kovacevich - Snohomish WA, US
Katie Olson - Kenmore WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica Ann Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Patricia Dianne McNeill - Federal Way WA, US
Danielle Marie Mitchell - Seattle WA, US
Dan Scott Allison - Lake Forrest Park WA, US
John A. Latham - Seattle WA, US
International Classification:
C07K 16/40
A61K 45/06
A61K 39/395
US Classification:
424450, 5303898, 5303917, 435188, 5303872, 4241581, 536 2353, 4353201, 435338, 4352523, 43525411, 4352542, 43525423, 43525422, 43525421, 4352543, 4352547, 4352546, 4352544, 435 696, 435 74, 5303913
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for PCSK9. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-PCSK9 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-PCSK9 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-PCSK9 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with PCSK9.

Anti-Ngf Compositions And Use Thereof

View page
US Patent:
20130336975, Dec 19, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/833338
Inventors:
Benjamin H. Dutzar - Seattle WA, US
Brian R. Kovacevich - Snohomish WA, US
Patricia Dianne McNeill - Federal Way WA, US
Danielle M. Mitchell - Seattle WA, US
Ethan W. Ojala - Snohomish WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica A. Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Betty Yu-Ching Chang - Cupertino CA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
International Classification:
C07K 16/22
US Classification:
4241351, 5303892, 5303873, 5303913, 5303917, 536 2353, 4353201, 435335, 4352542, 4352523, 43525411, 435419, 4241581, 435 71, 435328
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.

Anti-Ngf Compositions And Use Thereof

View page
US Patent:
20120148490, Jun 14, 2012
Filed:
Dec 1, 2011
Appl. No.:
13/309295
Inventors:
Benjamin H. Dutzar - Seattle WA, US
Brian R. Kovacevich - Snohomish WA, US
Patricia Dianne NcNeill - Federal Way WA, US
Danielle M. Mitchell - Seattle WA, US
Ethan W. Ojala - Snohomish WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica A. Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Betty Yu-Ching Chang - Cupertino CA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
International Classification:
A61K 39/395
C12N 15/13
A61K 49/00
A61K 51/10
A61P 29/00
A61P 25/00
A61P 19/10
A61P 35/00
A61P 1/16
A61P 25/06
A61P 31/04
A61P 21/00
C12N 15/63
C12N 5/10
C12N 1/21
C12N 1/15
C12N 1/19
C12N 9/96
C12P 21/02
A61P 37/08
C07K 16/22
US Classification:
424 149, 5303892, 5303873, 5303913, 536 2353, 4241581, 424 91, 5303917, 5303911, 4353201, 435335, 4352523, 435419, 43525411, 4352542, 43525423, 424 96, 435188, 530367, 435 696, 800 6
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.
Control profile
Danielle Mitchell from Las Vegas, NV, age ~40 Get Report